Cargando…

MERS-CoV vaccine candidates in development: The current landscape

Middle East respiratory syndrome coronavirus (MERS-CoV), an emerging infectious disease of growing global importance, has caused severe acute respiratory disease in more than 1600 people, resulting in more than 600 deaths. The high case fatality rate, growing geographic distribution and vaguely defi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Modjarrad, Kayvon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization; licensee Elsevier Ltd. 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115572/ https://www.ncbi.nlm.nih.gov/pubmed/27083424 http://dx.doi.org/10.1016/j.vaccine.2016.03.104

Ejemplares similares

Evaluation of candidate vaccine approaches for MERS-CoV
por: Wang, Lingshu, et al.
Publicado: (2015)

A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
por: Modjarrad, Kayvon, et al.
Publicado: (2016)

HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development
por: Shepherd, Brittany Ober, et al.
Publicado: (2022)

A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
por: Dearlove, Bethany, et al.
Publicado: (2020)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021)

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
por: Al-amri, Sawsan S., et al.
Publicado: (2017)

Toward Developing a Preventive MERS-CoV Vaccine—Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14–15, 2015
por: Excler, Jean-Louis, et al.
Publicado: (2016)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks
por: Joyce, M. Gordon, et al.
Publicado: (2020)

MERS-CoV
por: Müller, Marcel A
Publicado: (2014)

Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
por: Mahmud, Shafi, et al.
Publicado: (2021)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development
por: Zhou, Nan, et al.
Publicado: (2014)

A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
por: Park, Jung-Eun, et al.
Publicado: (2022)

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)

Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice
por: Li, Entao, et al.
Publicado: (2020)

564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity
por: Joyce, M G, et al.
Publicado: (2021)

Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023)

Proteomic landscape of SARS-CoV-2– and MERS-CoV–infected primary human renal epithelial cells
por: Kohli, Aneesha, et al.
Publicado: (2022)

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

MERS-CoV spike protein: Targets for vaccines and therapeutics
por: Wang, Qihui, et al.
Publicado: (2016)

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
por: Reusken, Chantal B.E.M., et al.
Publicado: (2016)

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
por: Modjarrad, Kayvon, et al.
Publicado: (2020)

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2023)

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)

MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination
por: Meyer zu Natrup, Christian, et al.
Publicado: (2023)

Development of Small-Molecule MERS-CoV Inhibitors
por: Liang, Ruiying, et al.
Publicado: (2018)

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
por: Oves, Mohammad, et al.
Publicado: (2020)

MERS-CoV diagnosis: An update
por: Al Johani, Sameera, et al.
Publicado: (2016)

Mers-CoV and Zika Virus
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa
por: Rolland, Morgane, et al.
Publicado: (2015)

A Computational Vaccine Designing Approach for MERS-CoV Infections
por: Ibrahim, Hiba Siddig, et al.
Publicado: (2020)

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017)

Advances in mRNA and other vaccines against MERS-CoV
por: Tai, Wanbo, et al.
Publicado: (2022)

MERS-CoV: in search of answers
por: Petherick, Anna
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qrge82apkgf76qtsbbno5h34vl